Making individualized choices about surgery and radiation is challenging for patients and clinicians. This project is looking at ways to help make these choices with testing. Evaluative tests can help inform who might benefit from certain treatments and how much.
Aim 1: Examine use of breast MRI and genetic testing for the BRCA1/2 mutation and the patient and clinician correlates of this testing.
Aim 2: Examine receipt of more or less aggressive surgical and radiation treatment and the patient and clinician correlates of these approaches.
Aim 3: Examine the extent to which patients are informed about treatments and satisfied with the decision-making process.
Newly diagnosed patients with breast cancer from the SEER registries in New Jersey and Georgia, as well as their surgeons.